EFG
SLS icon

Ethos Financial Group’s SELLAS Life Sciences SLS Stock Holding History

Ethos Financial Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Buy
+10,000
New +$69K 0.01% 599

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Ethos Financial Group's SLS Position: Q2 2026 in Review

Ethos Financial Group opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 10,000 shares worth $148K. The stake represents 0.01% of the portfolio and ranks #599 among its holdings.

192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Ethos Financial Group held 10,000 shares of SELLAS Life Sciences worth $148K as of Q2 2026.
  • SELLAS Life Sciences was a new Ethos Financial Group position in Q2 2026.
  • SELLAS Life Sciences made up 0.01% of Ethos Financial Group's portfolio in Q2 2026, its #599 holding.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Ethos Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.